2(1H)-quinolinone derivatives as novel anti-arteriostenotic agents showing anti-thrombotic and anti-hyperplastic activities. 1998

Y Koga, and Y Kihara, and M Okada, and Y Inoue, and S Tochizawa, and K Toga, and K Tachibana, and Y Kimura, and T Nishi, and H Hidaka
3rd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd., Japan.

In order to search for anti-arteriostenotic agents, a series of 2(1H)-quinolinone derivatives was synthesized and evaluated for anti-thrombotic activity and for anti-hyperplastic activity. From this series, (-)-6-[3-[3-cyclopropyl-3-[(1R,2R)-2-hydroxycyclohexyl]ureido]propoxy]-2 (1H)-quinolinone (1p, OPC-33509) was selected as the best candidate by balancing the efficacy on anti-thrombosis and anti-hyperplasia.

UI MeSH Term Description Entries
D006965 Hyperplasia An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. Hyperplasias
D010975 Platelet Aggregation Inhibitors Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. Antiaggregants, Platelet,Antiplatelet Agent,Antiplatelet Agents,Antiplatelet Drug,Blood Platelet Aggregation Inhibitor,Blood Platelet Antagonist,Blood Platelet Antiaggregant,PAR-1 Antagonists,Platelet Aggregation Inhibitor,Platelet Antagonist,Platelet Antagonists,Platelet Antiaggregant,Platelet Antiaggregants,Platelet Inhibitor,Protease-Activated Receptor-1 Antagonists,Antiplatelet Drugs,Blood Platelet Aggregation Inhibitors,Blood Platelet Antagonists,Blood Platelet Antiaggregants,Platelet Inhibitors,Agent, Antiplatelet,Aggregation Inhibitor, Platelet,Antagonist, Blood Platelet,Antagonist, Platelet,Antiaggregant, Blood Platelet,Antiaggregant, Platelet,Drug, Antiplatelet,Inhibitor, Platelet,Inhibitor, Platelet Aggregation,PAR 1 Antagonists,Platelet Antagonist, Blood,Platelet Antiaggregant, Blood,Protease Activated Receptor 1 Antagonists
D011804 Quinolines
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D000077407 Cilostazol A quinoline and tetrazole derivative that acts as a phosphodiesterase type 3 inhibitor, with anti-platelet and vasodilating activity. It is used in the treatment of PERIPHERAL VASCULAR DISEASES; ISCHEMIC HEART DISEASE; and in the prevention of stroke. 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone,OPC 13013,OPC-13013,Pletal
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001161 Arteriosclerosis Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries. Arterioscleroses
D013777 Tetrazoles
D013927 Thrombosis Formation and development of a thrombus or blood clot in BLOOD VESSELS. Atherothrombosis,Thrombus,Blood Clot,Blood Clots,Thromboses
D014508 Urea A compound formed in the liver from ammonia produced by the deamination of amino acids. It is the principal end product of protein catabolism and constitutes about one half of the total urinary solids. Basodexan,Carbamide,Carmol

Related Publications

Y Koga, and Y Kihara, and M Okada, and Y Inoue, and S Tochizawa, and K Toga, and K Tachibana, and Y Kimura, and T Nishi, and H Hidaka
November 1988, Chemical & pharmaceutical bulletin,
Y Koga, and Y Kihara, and M Okada, and Y Inoue, and S Tochizawa, and K Toga, and K Tachibana, and Y Kimura, and T Nishi, and H Hidaka
February 1987, Chemical & pharmaceutical bulletin,
Y Koga, and Y Kihara, and M Okada, and Y Inoue, and S Tochizawa, and K Toga, and K Tachibana, and Y Kimura, and T Nishi, and H Hidaka
October 1992, Journal of medicinal chemistry,
Y Koga, and Y Kihara, and M Okada, and Y Inoue, and S Tochizawa, and K Toga, and K Tachibana, and Y Kimura, and T Nishi, and H Hidaka
February 2022, Molecules (Basel, Switzerland),
Y Koga, and Y Kihara, and M Okada, and Y Inoue, and S Tochizawa, and K Toga, and K Tachibana, and Y Kimura, and T Nishi, and H Hidaka
June 2020, European journal of medicinal chemistry,
Y Koga, and Y Kihara, and M Okada, and Y Inoue, and S Tochizawa, and K Toga, and K Tachibana, and Y Kimura, and T Nishi, and H Hidaka
March 2009, Organic letters,
Y Koga, and Y Kihara, and M Okada, and Y Inoue, and S Tochizawa, and K Toga, and K Tachibana, and Y Kimura, and T Nishi, and H Hidaka
January 1978, Scandinavian journal of rheumatology. Supplement,
Y Koga, and Y Kihara, and M Okada, and Y Inoue, and S Tochizawa, and K Toga, and K Tachibana, and Y Kimura, and T Nishi, and H Hidaka
September 1985, Chemical & pharmaceutical bulletin,
Y Koga, and Y Kihara, and M Okada, and Y Inoue, and S Tochizawa, and K Toga, and K Tachibana, and Y Kimura, and T Nishi, and H Hidaka
January 2000, Journal of medicinal chemistry,
Y Koga, and Y Kihara, and M Okada, and Y Inoue, and S Tochizawa, and K Toga, and K Tachibana, and Y Kimura, and T Nishi, and H Hidaka
June 1987, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Copied contents to your clipboard!